CDK2 inhibitor compounds
TW202631619APending Publication Date: 2026-08-01ALEKSIA THERAPEUTICS INC
View PDF 0 Cites 0 Cited by
Patent Information
- Application Number
- TW114144160
- Authority / Receiving Office
- TW · TW
- Patent Type
- Applications
- Current Assignee / Owner
- Priority Date
- 2024-11-14
- Filing Date
- 2025-11-12
- Publication Date
- 2026-08-01
Abstract
The present disclosure provides CDK2 inhibitor compounds that can have a fused 6-6 bicyclic core, such as a naphthyridine, quinazoline, pyridopyrimidine or related isosteric core structure that is further substituted. Also provided herein are pharmaceutical compositions including the subject CDK2 inhibitor compounds, and methods for using compositions of the disclosure as anticancer therapeutics.
Need to check novelty before this filing date? Find Prior Art